国际标准期刊号: 2161-1165

Epidemiology: Open Access

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 安全点亮
  • 访问全球在线农业研究 (AGORA)
  • 国际农业与生物科学中心 (CABI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • CABI 全文
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

A Brief Note on Retroviral Therapy

Vinceti Marco

Reverse transcription is the process of creating complementary DNA (cDNA) from an RNA template using an enzyme known as a reverse transcriptase (RT). Eukaryotic cells use reverse transcriptases to extend the telomeres at the ends of their linear chromosomes, retrotransposon mobile genetic elements proliferate within the host genome, and viruses like HIV and hepatitis B use reverse transcriptases to replicate their genomes. Because transfers of information from RNA to DNA are explicitly held possible, the process does not violate the flows of genetic information as described by the classical central dogma. Retroviral RT has three sequential biochemical activities: ribonuclease H (RNase H), DNA-dependent DNA polymerase activity, and RNA-dependent DNA polymerase activity The enzyme is able to transform single-stranded RNA into double-stranded cDNA as a result of these activities taken together.